Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-20 Purchase | 2023-06-20 9:58 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 14,000 | $0.53 | $7,420 | 1,826,521 (Indirect Direct) | View |
| 2023-06-15 Purchase | 2023-06-20 06:10 am | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 15,021 | $0.53662 | $8,061 | 1,812,521 (Indirect Direct) | View |
| 2023-06-14 Purchase | 2023-06-15 7:15 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 10,000 | $0.49 | $4,900 | 1,797,500 (Indirect Direct) | View |
| 2022-12-23 Purchase | 2022-12-28 9:45 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner | 20,000 | $0.5 | $10,000 | 2,604,168 (Indirect Direct) | View |
| 2022-05-31 Purchase | 2022-06-03 06:08 am | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner | 12,000 | $1.9633 | $23,560 | 1,767,500 (Indirect Direct) | View |
| 2021-09-21 Purchase | 2021-09-22 3:09 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 5,000 | $4.31 | $21,550 | 2,088,834 (Indirect Direct) | View |
| 2021-08-17 Purchase | 2021-08-18 3:47 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 5,000 | $3 | $15,000 | 2,083,834 (Indirect Direct) | View |
| 2021-05-25 Purchase | 2021-05-25 9:45 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 4,000 | $5.38 | $21,520 | 2,087,834 (Indirect Direct) | View |
| 2020-12-23 Purchase | 2020-12-23 6:53 pm | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner | 1,000 | $7.2669 | $7,267 | 2,083,834 (Indirect Direct) | View |
| 2020-12-11 Purchase | 2020-12-14 08:45 am | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner | 500 | $8.5 | $4,250 | 2,082,834 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-23 Option Award | 2022-12-28 9:45 pm | N/A 2027-12-23 | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner | 483,334 | $0.48 | 2,604,168 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-28 6:54 pm | N/A 2027-02-25 | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 125,000 | $3.27 | 125,000 (Direct) | View |
| 2021-06-16 Ownership | 2022-02-14 9:21 pm | N/A 2026-06-26 | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer | 125,000 | $5.64 | 125,000 (Direct) | View |
Ownership(A) | 2021-06-29 4:18 pm | N/A N/A | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chairman and CEO 10% Owner | 0 | $0 | 1,740,000 (Indirect) | View |
Ownership | 2020-12-10 9:52 pm | N/A N/A | Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chairman & CEO 10% Owner | 0 | $0 | 2,082,334 (Indirect) | View |